4, 2024 — A new study shows strong alignment between real-world outcomes and those seen in clinical trials among a broad population of patients with relapsed or refractory multiple myeloma.
more than one focal lesion appears on an MRI scan Many people with myeloma show abnormalities in lab blood tests before they develop symptoms. Multiple myeloma requires active treatment if one or ...
Bone damage and kidney damage are frequently seen in patients with multiple myeloma. So X-rays, MRIs and PET scans are ...
Moving to oncology, we are excited to share preliminary data from the registrational Phase 2 iMMagine-1 study of anito-cel ...
The appeal of whole-body scans is clear: Who wouldn’t want ... cancer development throughout the body, or those with multiple myeloma, says Davenport. But these cases are exceedingly rare. " ...
A multiple myeloma diagnosis is a life event that can be overwhelming. Get trusted information for every step of your journey. Multiple myeloma can be tricky. That’s because it sometimes has no ...
It’s true that we’ve come a long way in recent years when it comes to treating multiple myeloma. More therapies are being developed, to the point where somebody diagnosed now is likely to have ...
Non-secretory myeloma is a rare form of myeloma. In people with this form, myeloma cells do not release an abnormal protein called paraprotein, making it harder to diagnose than other types of ...
A stem cell transplant can be a good treatment for multiple myeloma. A successful transplant gives someone with multiple myeloma new, healthy bone marrow. It replaces the bone marrow harmed by myeloma ...
NICE has defended a trio of decisions on new therapies for multiple myeloma, which saw two drugs approved for restricted use in England and Wales and a third turned down altogether. The recent ...
We do not know what causes MGUS. There may be a link to autoimmune diseases, genetics, or environmental factors. Like multiple myeloma, MGUS starts in a type of white blood cell called plasma cells.
Multiple myeloma is a rare type of cancer. It starts with the uncontrolled production of plasma cells. These are a type of white blood cell in the bone marrow. Healthy plasma cells make antibodies ...